Franklin Resources Portfolio holdings
Franklin Resources, Inc., commonly known as Franklin Templeton, was founded in 1947 by Rupert H. Johnson, Sr., and is headquartered in San Mateo, California, operating as a global investment management firm managing hundreds of billions in assets. The company offers a wide range of investment products, including mutual funds, ETFs, fixed-income portfolios, and alternative investments, serving individual investors, financial advisors, and institutions across over 150 countries. Known for its acquisition-driven growth—such as the 1992 purchase of Templeton Investments and the 2020 addition of Legg Mason—Franklin Templeton combines diverse strategies under a single brand, emphasizing both active management and income-focused solutions like its flagship Franklin Income Fund. With a reputation for adaptability and a client-centric approach, it remains a major player in the global asset management industry.
Top Buys
| 1 |
Merck
MRK
|
$263M |
| 2 |
Progressive
PGR
|
$255M |
| 3 |
Sempra
SRE
|
$232M |
| 4 |
NextEra Energy, Inc.
NEE
|
$228M |
| 5 |
Kenvue
KVUE
|
$198M |
Top Sells
| 1 |
Eli Lilly
LLY
|
$420M |
| 2 |
Amgen
AMGN
|
$404M |
| 3 |
NEE.PRQ
NextEra Energy, Inc. 6.219% Corporate Units
NEE.PRQ
|
$395M |
| 4 |
Zimmer Biomet
ZBH
|
$349M |
| 5 |
Willis Towers Watson
WTW
|
$339M |
Sector Composition
| 1 | Technology | 26.77% |
| 2 | Healthcare | 15.09% |
| 3 | Financials | 10.77% |
| 4 | Industrials | 9.7% |
| 5 | Consumer Discretionary | 8.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2776
Invesco S&P 500 Low Volatility ETF
SPLV
$7.94B
| – | – | -87,177 | Closed | -$5.48M |
|
2777
Royce Quant Small-Cap Quality Value ETF
SQLV
$26.1M
| – | – | -297 | Closed | -$10.9K |
|
2778
Stoke Therapeutics
STOK
$1.08B
| – | – | -12,643 | Closed | -$134K |
|
2779
Savara
SVRA
$567M
| – | – | -183,880 | Closed | -$587K |
|
2780
Synlogic
SYBX
$17M
| – | – | -77,998 | Closed | -$33.5K |
|
2781
Spyre Therapeutics
SYRE
$996M
| – | – | -31,364 | Closed | -$14.1K |
|
2782
Theravance Biopharma
TBPH
$699M
| – | – | -41,915 | Closed | -$434K |
|
2783
First Financial Corporation Common Stock
THFF
$699M
| – | – | -6,988 | Closed | -$227K |
|